NK/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NK/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 14, Issue 5, Pages 395-402
Publisher
Springer Nature
Online
2012-05-25
DOI
10.1007/s11912-012-0245-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
- (2011) R. Suzuki et al. BLOOD
- Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
- (2011) K. Karube et al. BLOOD
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- PRDM1 is a tumor suppressor gene in natural killer cell malignancies
- (2011) C. Kucuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia
- (2010) Ritsuro Suzuki INTERNATIONAL JOURNAL OF HEMATOLOGY
- Treatment of localized extranodal NK/T cell lymphoma, nasal type
- (2010) Seok Jin Kim et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
- (2009) R. Suzuki et al. ANNALS OF ONCOLOGY
- Differences between nasal and extranasal NK/T-cell lymphoma
- (2009) R. Suzuki et al. BLOOD
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
- (2009) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
- (2009) J Iqbal et al. LEUKEMIA
- L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature
- (2008) A. Jaccard et al. ANNALS OF ONCOLOGY
- Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study
- (2008) Jeeyun Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- (2008) W.-y. Au et al. BLOOD
- Extranodal NK/T-cell lymphoma: diagnosis and treatment cues
- (2008) Ritsuro Suzuki et al. HEMATOLOGICAL ONCOLOGY
- Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease
- (2008) Hiroshi Kimura et al. REVIEWS IN MEDICAL VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started